MTUS1 and cancer: We speculate that an abnormal switch from M1 to M2 would inhibit M1 macrophage-induced antitumor activity of T cell-mediated elimination and equilibrium phases during tumor progression induced by cancer-related inflammation; however, originally ATIP1 could prevent progression of cancer itself.